| Nicole Bussiere, MD | |
|
3400 Haydenpark Ln Ste 300, Henrico, VA 23233-7867 | |
| (804) 998-1600 | |
| (804) 998-1601 |
| Full Name | Nicole Bussiere |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 3400 Haydenpark Ln Ste 300, Henrico, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780065979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101276360 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bon Secours St Marys Hospital | Richmond, VA | Hospital |
| Thedacare Medical Center - Shawano | Shawano, WI | Hospital |
| Henrico Doctors' Hospital | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Partner Md Pc | 8022002617 | 24 |
News Archive
Transgene SA, a French biopharmaceutical company focused on discovering, developing and manufacturing targeted immunotherapies for the treatment of cancer and infectious diseases, announces that it has raised a total of €65.5 million via a two-step capital increase.
FIFA will hold a two-day Medical Conference in Zurich on 17 and 18 October 2009. Medical staff, but particularly administrators and officials from FIFA member associations worldwide, will enjoy an exceptional introduction to the latest achievements in football medicine and the many benefits for associations, communities, teams and players at all levels of play.
Emory University today announced an innovative new public-private drug development enterprise that will transition scientific discoveries more rapidly and efficiently from university laboratories into the marketplace. The new venture is expected to provide global solutions to address worldwide drug development and commercialization needs.
Creabilis, a late clinical stage European dermatology company with a focus on pruritus (itch), today announces it has treated the first patients in its Phase 2b study of its lead product, CT327, in patients with atopic dermatitis.
VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell (ES Cell) technologies for predictive toxicology and drug discovery, has announced new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells. VistaGen has exclusive rights for commercial use in its ES Cell-based tools platform for drug discovery and development.
› Verified 8 days ago
| Entity Name | Partner Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255409371 PECOS PAC ID: 8022002617 Enrollment ID: O20040417000601 |
News Archive
Transgene SA, a French biopharmaceutical company focused on discovering, developing and manufacturing targeted immunotherapies for the treatment of cancer and infectious diseases, announces that it has raised a total of €65.5 million via a two-step capital increase.
FIFA will hold a two-day Medical Conference in Zurich on 17 and 18 October 2009. Medical staff, but particularly administrators and officials from FIFA member associations worldwide, will enjoy an exceptional introduction to the latest achievements in football medicine and the many benefits for associations, communities, teams and players at all levels of play.
Emory University today announced an innovative new public-private drug development enterprise that will transition scientific discoveries more rapidly and efficiently from university laboratories into the marketplace. The new venture is expected to provide global solutions to address worldwide drug development and commercialization needs.
Creabilis, a late clinical stage European dermatology company with a focus on pruritus (itch), today announces it has treated the first patients in its Phase 2b study of its lead product, CT327, in patients with atopic dermatitis.
VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell (ES Cell) technologies for predictive toxicology and drug discovery, has announced new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells. VistaGen has exclusive rights for commercial use in its ES Cell-based tools platform for drug discovery and development.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Bussiere, MD 3400 Haydenpark Ln Ste 300, Henrico, VA 23233-7867 Ph: (804) 998-1600 | Nicole Bussiere, MD 3400 Haydenpark Ln Ste 300, Henrico, VA 23233-7867 Ph: (804) 998-1600 |
News Archive
Transgene SA, a French biopharmaceutical company focused on discovering, developing and manufacturing targeted immunotherapies for the treatment of cancer and infectious diseases, announces that it has raised a total of €65.5 million via a two-step capital increase.
FIFA will hold a two-day Medical Conference in Zurich on 17 and 18 October 2009. Medical staff, but particularly administrators and officials from FIFA member associations worldwide, will enjoy an exceptional introduction to the latest achievements in football medicine and the many benefits for associations, communities, teams and players at all levels of play.
Emory University today announced an innovative new public-private drug development enterprise that will transition scientific discoveries more rapidly and efficiently from university laboratories into the marketplace. The new venture is expected to provide global solutions to address worldwide drug development and commercialization needs.
Creabilis, a late clinical stage European dermatology company with a focus on pruritus (itch), today announces it has treated the first patients in its Phase 2b study of its lead product, CT327, in patients with atopic dermatitis.
VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell (ES Cell) technologies for predictive toxicology and drug discovery, has announced new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells. VistaGen has exclusive rights for commercial use in its ES Cell-based tools platform for drug discovery and development.
› Verified 8 days ago
Mr. Eric J Haacke-golden, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Haydenpark Ln Ste 300, Henrico, VA 23233 Phone: 804-998-1600 Fax: 804-998-1601 | |
Dr. Elizabeth R. Bigelow, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Haydenpark Ln Ste 300, Henrico, VA 23233 Phone: 804-998-1600 Fax: 804-282-0676 | |
Mr. David Keith Crossen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7603 Forest Ave Ste 301, Henrico, VA 23229 Phone: 804-421-7404 Fax: 804-421-7405 | |
Mark G Petrizzi, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Haydenpark Ln Ste 300, Henrico, VA 23233 Phone: 804-998-1600 Fax: 804-998-1601 | |
Ms. Ruth Arnetta Jones, LPN Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7515 Chamberlayne Ave., Henrico, VA 23227 Phone: 804-399-0515 Fax: 804-525-5941 | |
Angelika Jovin, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4722 S Laburnum Ave, Henrico, VA 23231 Phone: 804-604-2430 Fax: 877-471-2996 | |
Alexandra Marie Mullin, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 2400 E Parham Rd, Henrico, VA 23228 Phone: 423-260-0655 |